| 2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|---|
Facility deliveries, reported (N) | 1,284,356 | 1,426,434 | 1,675,409 | 1,795,109 | 1,881,194 |
Antepartum complications | Â | Â | Â | Â | Â |
Antepartum hemorrhage | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 |
Premature rupture of membranes | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 |
Anemia | 1.1 | 1.3 | 1.4 | 1.8 | 1.1 |
Malaria | 8.2 | 8.7 | 8.5 | 8.0 | 9.5 |
HIV (Stage III or IV) | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
Hypertensive disorders of pregnancy (total) | 1.3 | 1.4 | 1.1 | 1.1 | 1.0 |
Pregnancy induced hypertension | 0.6 | 0.6 | 0.6 | 0.5 | 0.4 |
Pre-eclampsia | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 |
Eclampsia | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 |
During / after delivery complications | Â | Â | Â | Â | Â |
Postpartum hemorrhage (PPH) | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 |
Obstructed labour | 2.3 | 2.2 | 1.9 | 1.9 | 1.8 |
Retained placenta | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
Third degree tear | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
Ruptured uterus | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Pre-eclampsia | 0.7 | 0.7 | 0.5 | 0.6 | 0.6 |
Eclampsia | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 |
Sepsis | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
Interventions | Â | Â | Â | Â | Â |
Antibiotics given | 10.1 | 9.9 | 8.8 | 8.8 | 8.8 |
Oxytocin administered (AMTSL) | 94.0 | 95.6 | 95.3 | 97.0 | 90.6 |
Magnesium sulphate: given per 100* | 36.8 | 35.0 | 38.2 | 36.6 | 35.6 |
Uterotonics for complications^ | 17.8 | 12.1 | 9.4 | 8.6 | 8.7 |
 C-section per 100 institutional deliveries | 10.2 | 10.2 | 9.6 | 9.7 | 10.1 |
Total | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |